Table 2

Cox proportional hazard model adjusting for age and sex

n events/nHR (95% CI)P
All-cause mortality
    Nonobese insulin-sensitive subjects141/708
    Obese insulin-sensitive subjects7/430.99 (0.46–2.11)0.97
    Nonobese insulin-resistant subjects241/9231.11 (0.90–1.36)0.35
    Obese insulin-resistant subjects106/3371.40 (1.08–1.81)0.01
CVD mortality
    Nonobese insulin-sensitive subjects58/708
    Obese insulin-sensitive subjects2/430.73 (0.18–3.00)0.66
    Nonobese insulin-resistant subjects112/9231.19 (0.86–1.64)0.29
    Obese insulin-resistant subjects49/3371.61 (1.10–2.36)0.015
Cancer mortality
    Nonobese insulin-sensitive subjects51/708
    Obese insulin-sensitive subjects3/431.04 (0.32–3.30)0.95
    Nonobese insulin-resistant subjects85/9231.09 (0.78–1.52)0.64
    Obese insulin-resistant subjects41/3371.52 (1.02–2.26)0.04